Delivery Order 75F40119D10041-75F40123F19013
- Not listed
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
- Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
- This $1,134,088.88 firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. to provide a Common Data Harmonization System FIDLE Integration. The contract has a period of performance through March 31, 2024 and is not set aside. Dnanexus, a for-profit organization, has a history of supporting FDA initiatives like the PrecisionFDA program, providing cloud-based bioinformatics tools and genomic analysis platform services to the regulatory...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company based in Mountain View, California. The contract, valued at $473,879.68, is for the operation and maintenance of the PrecisionFDA public instance of the Genomics Sequence and Regulatory Science (GSRS) platform. PrecisionFDA is a cloud-based genomics data management and analysis platform that enables collaboration between researchers and regulatory reviewers. This delivery...
- The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
- The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...
- This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
- The Food and Drug Administration awarded a definitive, firm fixed-price contract to DNAnexus, Inc., a Mountain View, California-based cloud-based genomics and regulatory science solutions provider, on September 9, 2024, with a ceiling value of $1.05 million. The contract involves development of the PRISM High-Impact Platform Pilot, a pre-submission validation tool for eCTDs (electronic Common Technical Documents) designed to facilitate sponsor-reviewer interaction within the FDA's regulatory...
- 75F40119D10041Indefinite Delivery Contract
- 75F40119D10041-75F40123F19013Delivery Order
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported the FDA's PrecisionFDA program, which utilizes precision medicine approaches to advance regulatory science. This delivery order is part of a larger $20 million indefinite delivery contract the company holds with the FDA for ongoing provision of the PrecisionFDA collaborative omics environment and bioinformatics tools.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | $0 | 11/26/24 | |
| P00001 | Funding Only Action | $409.6k | 1/2/24 | |
| Not listed | Not listed | $3.7m | 9/22/23 |